XML 17 R6.htm IDEA: XBRL DOCUMENT v3.26.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
PREFERRED STOCK
COMMON STOCK
ADDITIONAL PAID-IN CAPITAL
ACCUMULATED DEFICIT
ACCUMULATED OTHER COMPREHENSIVE INCOME
Beginning balance (in shares) at Dec. 31, 2024   15,000        
Beginning balance at Dec. 31, 2024   $ 0        
Beginning balance (in shares) at Dec. 31, 2024     3,405,692      
Beginning balance at Dec. 31, 2024 $ 32,586   $ 0 $ 430,210 $ (397,678) $ 54
Increase (Decrease) in Shareholders' Equity            
Net Loss (1,515)       (1,515)  
Reclassification of Realized Gain on Available-for-Sale Investments (56)         (56)
Unrealized Gain on Available-for-Sale Investments 62         62
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)     20,098      
Stock-based Compensation 445     445    
Ending balance (in shares) at Mar. 31, 2025   15,000        
Ending balance at Mar. 31, 2025   $ 0        
Ending balance (in shares) at Mar. 31, 2025     3,425,790      
Ending balance at Mar. 31, 2025 31,522   $ 0 430,655 (399,193) 60
Beginning balance (in shares) at Dec. 31, 2024   15,000        
Beginning balance at Dec. 31, 2024   $ 0        
Beginning balance (in shares) at Dec. 31, 2024     3,405,692      
Beginning balance at Dec. 31, 2024 32,586   $ 0 430,210 (397,678) 54
Increase (Decrease) in Shareholders' Equity            
Net Loss (4,760)          
Reclassification of Realized Gain on Available-for-Sale Investments $ (181)          
Ending balance (in shares) at Sep. 30, 2025   15,000        
Ending balance at Sep. 30, 2025   $ 0        
Ending balance (in shares) at Sep. 30, 2025 3,940,528   3,940,528      
Ending balance at Sep. 30, 2025 $ 37,019   $ 0 439,384 (402,438) 73
Beginning balance (in shares) at Mar. 31, 2025   15,000        
Beginning balance at Mar. 31, 2025   $ 0        
Beginning balance (in shares) at Mar. 31, 2025     3,425,790      
Beginning balance at Mar. 31, 2025 31,522   $ 0 430,655 (399,193) 60
Increase (Decrease) in Shareholders' Equity            
Net Loss (1,492)       (1,492)  
Reclassification of Realized Gain on Available-for-Sale Investments (64)         (64)
Unrealized Gain on Available-for-Sale Investments 61         61
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)     17,244      
Stock-based Compensation 382     382    
Ending balance (in shares) at Jun. 30, 2025   15,000        
Ending balance at Jun. 30, 2025   $ 0        
Ending balance (in shares) at Jun. 30, 2025     3,443,034      
Ending balance at Jun. 30, 2025 30,409   $ 0 431,037 (400,685) 57
Increase (Decrease) in Shareholders' Equity            
Net Loss (1,753)       (1,753)  
Reclassification of Realized Gain on Available-for-Sale Investments (61)         (61)
Unrealized Gain on Available-for-Sale Investments $ 77         77
Issuance of common stock, net of offering costs/At-The-Market (in shares) 496,463          
Issuance of Common Stock, net of offering costs/At-the-Market Offering $ 7,799     7,799    
Issuance of Common Stock upon Exercise of Options (in shares)     1,031      
Issuance of Common Stock upon Exercise of Options 16     16    
Stock-based Compensation $ 532     532    
Ending balance (in shares) at Sep. 30, 2025   15,000        
Ending balance at Sep. 30, 2025   $ 0        
Ending balance (in shares) at Sep. 30, 2025 3,940,528   3,940,528      
Ending balance at Sep. 30, 2025 $ 37,019   $ 0 439,384 (402,438) 73
Beginning balance (in shares) at Dec. 31, 2025 15,000 15,000        
Beginning balance at Dec. 31, 2025 $ 0 $ 0        
Beginning balance (in shares) at Dec. 31, 2025 3,940,530   3,940,530      
Beginning balance at Dec. 31, 2025 $ 36,981   $ 0 439,842 (402,992) 131
Increase (Decrease) in Shareholders' Equity            
Net Loss (1,605)       (1,605)  
Reclassification of Realized Gain on Available-for-Sale Investments (120)         (120)
Unrealized Gain on Available-for-Sale Investments 122         122
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)     6,499      
Stock-based Compensation 479     479    
Ending balance (in shares) at Mar. 31, 2026   15,000        
Ending balance at Mar. 31, 2026   $ 0        
Ending balance (in shares) at Mar. 31, 2026     3,947,029      
Ending balance at Mar. 31, 2026 $ 35,857   $ 0 440,321 (404,597) 133
Beginning balance (in shares) at Dec. 31, 2025 15,000 15,000        
Beginning balance at Dec. 31, 2025 $ 0 $ 0        
Beginning balance (in shares) at Dec. 31, 2025 3,940,530   3,940,530      
Beginning balance at Dec. 31, 2025 $ 36,981   $ 0 439,842 (402,992) 131
Increase (Decrease) in Shareholders' Equity            
Net Loss (5,101)          
Reclassification of Realized Gain on Available-for-Sale Investments $ (378)          
Ending balance (in shares) at Sep. 30, 2026 15,000 15,000        
Ending balance at Sep. 30, 2026 $ 0 $ 0        
Ending balance (in shares) at Sep. 30, 2026 3,971,968   3,971,968      
Ending balance at Sep. 30, 2026 $ 33,135   $ 0 441,115 (408,093) 113
Beginning balance (in shares) at Mar. 31, 2026   15,000        
Beginning balance at Mar. 31, 2026   $ 0        
Beginning balance (in shares) at Mar. 31, 2026     3,947,029      
Beginning balance at Mar. 31, 2026 35,857   $ 0 440,321 (404,597) 133
Increase (Decrease) in Shareholders' Equity            
Net Loss (1,172)       (1,172)  
Reclassification of Realized Gain on Available-for-Sale Investments (130)         (130)
Unrealized Gain on Available-for-Sale Investments 127         127
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)     25,000      
Stock-based Compensation $ 403     403    
Ending balance (in shares) at Jun. 30, 2026   15,000        
Ending balance at Jun. 30, 2026   $ 0        
Ending balance (in shares) at Jun. 30, 2026 39,720,299   3,972,029      
Ending balance at Jun. 30, 2026 $ 35,085   $ 0 440,724 (405,769) 130
Increase (Decrease) in Shareholders' Equity            
Net Loss (2,324)       (2,324)  
Reclassification of Realized Gain on Available-for-Sale Investments (128)         (128)
Unrealized Gain on Available-for-Sale Investments $ 111         111
Cash Paid In Lieu of Fractional Shares In Reverse Stock Split (in shares) (61)          
Stock-based Compensation $ 391     391    
Ending balance (in shares) at Sep. 30, 2026 15,000 15,000        
Ending balance at Sep. 30, 2026 $ 0 $ 0        
Ending balance (in shares) at Sep. 30, 2026 3,971,968   3,971,968      
Ending balance at Sep. 30, 2026 $ 33,135   $ 0 $ 441,115 $ (408,093) $ 113